CBS 2019
CBSMD教育中心
English

DAPT Duration

科研文章

荐读文献

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study

Original Research2018 Sep 24. [Epub ahead of print]

JOURNAL:Cardiol J. Article Link

Coronary plaque redistribution after stent implantation is determined by lipid composition: A NIRS-IVUS analysis

Roleder T, Dobrolinska M, Pociask E et al. Keywords: IVUS; near-infrared spectroscopy; plaque redistribution; stent edges; stenting

ABSTRACT